Sushil Sharma1, A K Sharma2, Htet Wai Moe3, Amol Khanapure3, Prafull Mohan1. 1. Professor, Department of Pharmacology, Armed Forces Medical College, Pune, India. 2. Professor & Head, Department of Pharmacology, Armed Forces Medical College, Pune, India. 3. Resident, Department of Pharmacology, Armed Forces Medical College, Pune, India.
Abstract
Background: As per regulations, drugs have to be used within their shelf life and must be discarded after their expiry date. The present study was conducted in commonly used analgesic agents to investigate the change in the physical, chemical, and efficacy parameters of the drugs over a period of two years after their expiry date. Methods: The drugs studied were Tab Ibuprofen, Tab Diclofenac, Tab Piroxicam, Inj Diclofenac, and Inj Piroxicam. The parameters investigated were chemical potency, physical stability, and analgesic efficacy. Testing for these parameters was carried out once before expiry to establish the baseline followed by at expiry, and then every six months for two years post expiry date. Results: The active ingredient in all the drugs were within the accepted range as per IP during the study period indicating that they retained their potency up to a period of two years post expiry. The analgesic efficacy as determined by the "Radiant Heat Tail flick" and "Acetic acid-induced writhing" model also showed no significant difference in the Maximum Possible Efficacy and Percent protection, indicating that the drugs retained their efficacy. There was a slight difference in the dissolution times at expiry as compared to different time periods in the case of Ibuprofen and Diclofenac, while there are was no statistical difference in the disintegration times during the study period. Conclusion: The analgesic drugs in our study retained their chemical potency, physical stability and analgesic efficacy up to a period of two years after expiry. The expiry date of a drug, as estimated currently, is not an accurate reflection of its actual shelf life.
Background: As per regulations, drugs have to be used within their shelf life and must be discarded after their expiry date. The present study was conducted in commonly used analgesic agents to investigate the change in the physical, chemical, and efficacy parameters of the drugs over a period of two years after their expiry date. Methods: The drugs studied were Tab Ibuprofen, Tab Diclofenac, Tab Piroxicam, Inj Diclofenac, and Inj Piroxicam. The parameters investigated were chemical potency, physical stability, and analgesic efficacy. Testing for these parameters was carried out once before expiry to establish the baseline followed by at expiry, and then every six months for two years post expiry date. Results: The active ingredient in all the drugs were within the accepted range as per IP during the study period indicating that they retained their potency up to a period of two years post expiry. The analgesic efficacy as determined by the "Radiant Heat Tail flick" and "Acetic acid-induced writhing" model also showed no significant difference in the Maximum Possible Efficacy and Percent protection, indicating that the drugs retained their efficacy. There was a slight difference in the dissolution times at expiry as compared to different time periods in the case of Ibuprofen and Diclofenac, while there are was no statistical difference in the disintegration times during the study period. Conclusion: The analgesic drugs in our study retained their chemical potency, physical stability and analgesic efficacy up to a period of two years after expiry. The expiry date of a drug, as estimated currently, is not an accurate reflection of its actual shelf life.
Authors: Saeed R Khan; Ravikanth Kona; Patrick J Faustino; Abhay Gupta; Jeb S Taylor; Donna A Porter; Mansoor Khan Journal: J Pharm Sci Date: 2014-03-12 Impact factor: 3.534
Authors: Joshua G Schier; Padinjarekuttu R Ravikumar; Lewis S Nelson; Michael B Heller; Mary Ann Howland; Robert S Hoffman Journal: Acad Emerg Med Date: 2004-04 Impact factor: 3.451
Authors: Angela Acosta; Egdda Patricia Vanegas; Joan Rovira; Brian Godman; Tomasz Bochenek Journal: Front Pharmacol Date: 2019-07-19 Impact factor: 5.810